All News Navamedic ASA

Equities

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-05-21 am EDT			5-day change	1st Jan Change
34.6 ^NOK	+1.76%		+2.98%	-5.72%

May. 06	Navamedic Rolls Out Erectile Dysfunction Drug in Sweden	MT
Apr. 30	Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals	May. 16	AQ
Navamedic ASA: Notice of Annual General Meeting	May. 14	AQ
Navamedic Rolls Out Erectile Dysfunction Drug in Sweden	May. 06	MT
Navamedic ASA: Broad launch for Eroxon® in Sweden today	May. 06	AQ
Navamedic ASA: Annual Report 2023	Apr. 30	AQ
Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
Navamedic Q1 2024: Successful product launch and steady operational progress	Apr. 30	AQ
Navamedic ASA: Invitation to 2024 1st quarter presentation	Apr. 23	AQ
Disclosure in NAVAMEDIC ASA	Mar. 21	AQ
Major shareholder disclosure in Navamedic ASA	Mar. 18	AQ
Navamedic ASA - Mandatory notification of trade by primary insider	Mar. 15	AQ
Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options	Mar. 15	AQ
Navamedic welcomes new shareholders	Mar. 13	AQ
Navamedic ASA - Notification of Major Holdings	Mar. 13	AQ
Ingerø Reiten Investment Divests Navamedic Stake in NOK95 Million Deal	Mar. 13	MT
Navamedic ASA: Notification of major shareholding and mandatory notification of trade	Mar. 12	AQ
Contemplated block sale of existing shares in Navamedic ASA	Mar. 12	AQ
An unknown buyer acquired unknown minority stake in Navamedic ASA (OB:NAVA) from Ingerø Reiten Investment Company As for NOK 95 million.	Mar. 11	CI
Navamedic ASA: Mandatory notification of trade	Feb. 22	AQ
Navamedic ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15	CI

No results for this search